Female gender is a factor of worse outcome in acute stroke even after thrombolytic treatment

Int J Stroke. 2011 Aug;6(4):371-2. doi: 10.1111/j.1747-4949.2011.00627.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Male
  • Risk Factors
  • Sex Factors
  • Stroke / drug therapy*
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator